272 related articles for article (PubMed ID: 8110037)
1. [Predicting the clinical efficacy of house dust mite immunotherapy in bronchial asthmatics by multiple quantification analysis type II].
Soda R; Okada C; Takahashi K; Katagi S; Kanehiro A; Kimura G; Okamoto S; Tada S; Kimura I
Arerugi; 1993 Dec; 42(12):1771-5. PubMed ID: 8110037
[TBL] [Abstract][Full Text] [Related]
2. [A study to predict the clinical efficacy of house dust mite immunotherapy in bronchial asthmatics].
Soda R; Takahashi K; Miyashita K; Katagi S; Yamagata K; Gotou M; Kimura G; Okamoto S; Okano T; Kawada N
Arerugi; 1993 Apr; 42(4):522-8. PubMed ID: 8323449
[TBL] [Abstract][Full Text] [Related]
3. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program.
Huss K; Adkinson NF; Eggleston PA; Dawson C; Van Natta ML; Hamilton RG
J Allergy Clin Immunol; 2001 Jan; 107(1):48-54. PubMed ID: 11149990
[TBL] [Abstract][Full Text] [Related]
4. Bronchial asthma in the Nigerian savanna region. A clinical and laboratory study of 106 patients with a review of the literature on asthma in the tropics.
Warrell DA; Fawcett IW; Harrison BD; Agamah AJ; Ibu JO; Pope HM; Maberly DJ
Q J Med; 1975 Apr; 44(174):325-47. PubMed ID: 1101285
[TBL] [Abstract][Full Text] [Related]
5. [An evaluation of the long-term effect of clustered immunotherapy in house-dust-mite-sensitive adult bronchial asthma].
Nagata M; Tanaka K
Arerugi; 2001 May; 50(5):435-9. PubMed ID: 11436329
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the relationship between cockroach sensitivity and house-dust-mite sensitivity in Turkish asthmatic patients.
Uzel A; Capan N; Canbakan S; Yurdakul AS; Dursun B
Respir Med; 2005 Aug; 99(8):1032-7. PubMed ID: 15950145
[TBL] [Abstract][Full Text] [Related]
7. An analysis of skin prick test reactions in asthmatics in a hot climate and desert environment.
Bener A; Safa W; Abdulhalik S; Lestringant GG
Allerg Immunol (Paris); 2002 Oct; 34(8):281-6. PubMed ID: 12449666
[TBL] [Abstract][Full Text] [Related]
8. [A clinical evaluation of clustered immunotherapy in house-dust-mite-sensitive adult bronchial asthma].
Nagata M
Arerugi; 1998 Apr; 47(4):426-33. PubMed ID: 9621470
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of allergen specific immunotherapy in adult house-dust-mite-sensitive bronchial asthma: impact on disease severity and medical cost].
Nagata M; Tabe K; Yamamoto H; Sakamoto Y; Matsuo H
Arerugi; 1999 Dec; 48(12):1316-21. PubMed ID: 10666919
[TBL] [Abstract][Full Text] [Related]
10. [The analysis of factors contributing to the safety and efficacy of rush immunotherapy in bronchial asthma].
Nagata M; Tabe K; Yamamoto H; Maruo H; Kiuch H; Sakamoto Y; Yamamoto K; Dohi Y
Arerugi; 1993 May; 42(5):628-34. PubMed ID: 8323461
[TBL] [Abstract][Full Text] [Related]
11. Influence of hyposensitization with Dermatophagoides pteronyssinus extract on clinical score, total and specific IgE levels, and skin test in asthmatic patients.
Delaunois L; Salamon E; Prignot J
Ann Allergy; 1985 Aug; 55(2):150-2. PubMed ID: 4025957
[TBL] [Abstract][Full Text] [Related]
12. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of efficacy and safety of intrabronchial specific immunotherapy with allergy medication against allergies to house mites among patients with bronchial asthma].
Zietkowski Z
Pol Merkur Lekarski; 1999 May; 6(35):239-41. PubMed ID: 10437390
[TBL] [Abstract][Full Text] [Related]
14. Allergy to house dust mites and asthma.
Milián E; Díaz AM
P R Health Sci J; 2004 Mar; 23(1):47-57. PubMed ID: 15125219
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
[TBL] [Abstract][Full Text] [Related]
16. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of mite asthma (author's transl)].
Kirsten D
Z Erkr Atmungsorgane; 1980; 155(1):120-4. PubMed ID: 7210736
[TBL] [Abstract][Full Text] [Related]
18. [Hypersensitivity to cockroach allergen among children with bronchial asthma living in the Łódź district].
Stelmach I; Brzozowska A; Jerzyńska J; Podsiadłowicz-Borzecka M; Bobrowska M; Majak P; Kuna P
Pol Merkur Lekarski; 2000 Oct; 9(52):657-61. PubMed ID: 11144051
[TBL] [Abstract][Full Text] [Related]
19. [A clinical evaluation of rush immunotherapy in adult patients with severe bronchial asthma].
Nagata M; Yamamoto H; Tabe K; Tanaka K; Kimura I; Sakamoto K; Sakamoto Y; Yamamoto K; Dohi Y
Arerugi; 1989 Dec; 38(12):1319-26. PubMed ID: 2634374
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
